CYTOMX THERAPEUTICS INC shareholders Q3 2023

CYTOMX THERAPEUTICS INC's ticker is CTMX and the CUSIP is 23284F105. A total of 63 filers reported holding CYTOMX THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.10 and the average weighting 0.0%.

CYTOMX THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
TANG CAPITAL MANAGEMENT LLC 6,450,000$8,320,5001.17%
BVF INC/IL 6,595,801$8,508,5830.23%
Bronte Capital Management Pty Ltd. 925,245$1,193,5660.12%
Formidable Asset Management, LLC 318,111$410,3630.09%
Congress Park Capital LLC 112,450$145,0610.08%
Forefront Analytics, LLC 49,421$63,7540.04%
Ground Swell Capital, LLC 10,966$14,1460.02%
Clearline Capital LP 196,583$253,5920.02%
CORNERCAP INVESTMENT COUNSEL INC 81,352$104,9440.02%
ACADIAN ASSET MANAGEMENT LLC 2,646,190$3,4120.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 372,124$480,0400.01%
Tidal Investments LLC 318,111$410,3630.01%
Laurion Capital Management LP 1,188,225$1,532,8100.01%
JACOBS LEVY EQUITY MANAGEMENT, INC 1,052,105$1,357,2150.01%
UBS OCONNOR LLC 259,965$335,3550.01%
Byrne Asset Management LLC 8,000$10,0000.01%
AlphaMark Advisors, LLC 10,548$140.01%
WestHill Financial Advisors, Inc. 17,082$22,0360.01%
Assenagon Asset Management S.A. 425,921$549,4380.00%
Renaissance Technologies 930,100$1,2000.00%
External links

This page lists CYTOMX THERAPEUTICS INC's shareholders in Q3 2023. To view CYTOMX THERAPEUTICS INC's shareholder history, click here.